[go: up one dir, main page]

SE8701765D0 - Analysis method and means therefor - Google Patents

Analysis method and means therefor

Info

Publication number
SE8701765D0
SE8701765D0 SE8701765A SE8701765A SE8701765D0 SE 8701765 D0 SE8701765 D0 SE 8701765D0 SE 8701765 A SE8701765 A SE 8701765A SE 8701765 A SE8701765 A SE 8701765A SE 8701765 D0 SE8701765 D0 SE 8701765D0
Authority
SE
Sweden
Prior art keywords
virus
disclosed
analysis method
means therefor
related human
Prior art date
Application number
SE8701765A
Other languages
English (en)
Other versions
SE8701765L (sv
Original Assignee
Statens Bakteriologiska Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Bakteriologiska Lab filed Critical Statens Bakteriologiska Lab
Priority to SE8701765A priority Critical patent/SE8701765L/sv
Publication of SE8701765D0 publication Critical patent/SE8701765D0/sv
Priority to AU17110/88A priority patent/AU1711088A/en
Priority to PCT/SE1988/000218 priority patent/WO1988008449A1/en
Publication of SE8701765L publication Critical patent/SE8701765L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/112—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8701765A 1987-04-28 1987-04-28 Analysmetod och medel foer denna SE8701765L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8701765A SE8701765L (sv) 1987-04-28 1987-04-28 Analysmetod och medel foer denna
AU17110/88A AU1711088A (en) 1987-04-28 1988-04-28 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof
PCT/SE1988/000218 WO1988008449A1 (en) 1987-04-28 1988-04-28 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701765A SE8701765L (sv) 1987-04-28 1987-04-28 Analysmetod och medel foer denna

Publications (2)

Publication Number Publication Date
SE8701765D0 true SE8701765D0 (sv) 1987-04-28
SE8701765L SE8701765L (sv) 1988-10-29

Family

ID=20368350

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701765A SE8701765L (sv) 1987-04-28 1987-04-28 Analysmetod och medel foer denna

Country Status (3)

Country Link
AU (1) AU1711088A (sv)
SE (1) SE8701765L (sv)
WO (1) WO1988008449A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345375B1 (en) * 1988-06-09 1995-03-22 N.V. Innogenetics S.A. HIV-3 retrovirus and its use
US5223423A (en) * 1989-03-31 1993-06-29 United States Of America Characterization of replication competent human immunodeficiency type 2 proviral clone hiv-2sbl/isy
ES2110283T3 (es) * 1989-05-31 1998-02-01 Pasteur Institut Proteinas y glicoproteinas de anticuerpos de los retrovirus hiv-2 eho dirigidos contra ellos - aplicacion para la diagnosis.
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
DE3690028C2 (de) * 1985-01-15 1995-05-24 Cancer Res Inst Verfahren und Testkit für die Analyse einer biologischen Probe auf Antikörper gegen Retroviren
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
WO1987004459A1 (fr) * 1986-01-22 1987-07-30 Institut Pasteur Retrovirus du type hiv-2 susceptible de provoquer le sida, et ses constituants antigeniques et nucleiques
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses

Also Published As

Publication number Publication date
SE8701765L (sv) 1988-10-29
WO1988008449A1 (en) 1988-11-03
AU1711088A (en) 1988-12-02

Similar Documents

Publication Publication Date Title
Osterhaus et al. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
SE8604007D0 (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
NO169844C (no) Htlv-iii (env)-peptider
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
BR9305435A (pt) Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
ES553757A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
SE8701765D0 (sv) Analysis method and means therefor
EA200300335A1 (ru) Регуляторные и вспомогательные пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
Falkler Jr et al. Human antibody to dengue soluble complement-fixing (SCF) antigens
ES2056075T3 (es) Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.
DK56389D0 (da) Forhindring og behandling af retroviralt frembragte sygdomme
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
KR890008318A (ko) 플라스모듐 팔시파룸의 재조합 히스티딘-고함유 단백질, 이의 제조방법 및 용도
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
UA8704A1 (uk) Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу
DK340887D0 (da) Antigenisk peptid isoleret fra 28 kd proteinet fras. mansoni og fremgangsmaade til dets isolering, monoklonale antistoffer, der genkender mindst en epitop af peptidet og dets anvendelse til syntese af antistoffer
LIU et al. Preparation of refined antimeasles gamma globulin from immunized goats and pigs
DE3475309D1 (en) Synthetic peptide, immune globulin and process for immunizing a mammal

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701765-3

Effective date: 19901101

Format of ref document f/p: F